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Abstract
Leptin exerts its action by binding to and activating the long form of leptin receptors (LEPRb). LEPRb activates JAK2 that
subsequently phosphorylates and activates STAT3. The JAK2/STAT3 pathway is required for leptin control of energy balance
and body weight. Defects in leptin signaling lead to leptin resistance, a primary risk factor for obesity. Body weight is also
regulated by nutrients, including glucose. Defects in glucose sensing also contribute to obesity. Here we report crosstalk
between leptin and glucose. Glucose starvation blocked the ability of leptin to stimulate tyrosyl phosphorylation and
activation of JAK2 and STAT3 in a variety of cell types. Glucose dose-dependently enhanced leptin signaling. In contrast,
glucose did not enhance growth hormone-stimulated phosphorylation of JAK2 and STAT5. Glucose starvation or 2-
deoxyglucose-induced inhibition of glycolysis activated AMPK and inhibited leptin signaling; pharmacological inhibition of
AMPK restored the ability of leptin to stimulate STAT3 phosphorylation. Conversely, pharmacological activation of AMPK
was sufficient to inhibit leptin signaling and to block the ability of glucose to enhance leptin signaling. These results suggest
that glucose and/or its metabolites play a permissive role in leptin signaling, and that glucose enhances leptin sensitivity at
least in part by attenuating the ability of AMPK to inhibit leptin signaling.
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Introduction
Leptin is a metabolic hormone that is required for the
maintenance of normal energy balance and body weight [1].
Leptin is secreted into the bloodstream from adipose tissues [2]. It
suppresses food intake, increases energy expenditure, and
promotes weight loss primarily by binding to and activating
LEPRb in the hypothalamus [1]. Genetic deficiency of leptin or
LEPRb results in hyperphagia and severe obesity in both rodents
and humans [2,3,4,5,6]. However, circulating leptin levels increase
under most obesity conditions [7,8]; furthermore, diet-induced
obesity is associated with a reduced ability of leptin to suppress
both food intake and body weight gain [1,7,9]. Leptin resistance is
believed to be the primary risk factor for obesity [1]; however, the
underlying molecular mechanisms for leptin resistance remain
largely unknown.
Defects in leptin signaling are likely to be a major contributor to
leptin resistance [1]. LEPRb is a cytokine receptor family member
that binds to Janus kinase 2 (JAK2), a cytoplasmic tyrosine kinase
[1]. Upon leptin binding, LEPRb activates its associated JAK2
that in turn phosphorylates LEPRb at multiple tyrosines, including
Tyr
985, Tyr
1077, and Tyr
1138 [10,11]. Phosphorylated Tyr
985 binds
to SHP2, leading to activation of the ERK pathway [11,12,13].
Brain-specific deletion of SHP2 results in leptin resistance and
obesity, suggesting that the LEPRb/SHP2/ERK pathway is
required for a full leptin action [14]. Phospho-Tyr
985 also binds
to SOCS3, which negatively regulates leptin signaling [15].
Phospho-Tyr
1077 binds to Signal Transducer and Activator of
Transcription (STAT) 5 [16,17]. Phospho-Tyr
1138 recruits STAT3,
thus allowing JAK2 to phosphorylate and activate STAT3 [12].
The JAK2/STAT3 pathway is the best-understood pathway in
leptin action. Brain specific deletion of STAT3 results in leptin
resistance and obesity in mice [18]. Replacement of Tyr
1138 with
Phe or Ala also results in severe leptin resistance and obesity
[19,20]. These observations indicate that the JAK2/STAT3
pathway is required for leptin regulation of energy balance and
body weight.
Energy balance and body weight is also regulated by nutrients,
including glucose [21]. Hypothalamic glucopenia (glucose
deficit) promotes feeding [22,23]. Glucose is a metabolic fuel
that is metabolized to generate ATP through glycolysis and the
tricarboxylic acid cycle. Glucose or its metabolites serve as
biosynthetic precursors for lipids and various glycoproteins.
Additionally, glucose and its metabolites are also involved in cell
signaling. Glucose inhibits KATP channels in hypothalamic
neurons, thus increasing cell excitability [24,25]. Glucose starva-
tion stimulates 59-AMP-activated protein kinase (AMPK), a
molecular energy sensor, in many cell types, including hypotha-
lamic neurons [26,27]. Glucose-sensing neurons are located in
multiple regions in the central nervous system (CNS), including the
hypothalamus, brain stem, and amygdala, and hypothalamic
glucose sensing is believed to play an important role in energy
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inhibits AgRP neurons, in the arcuate nucleus of the hypothal-
amus [28]. Leptin also stimulates POMC neurons and inhibits
AgRP neurons, two subpopulations of hypothalamic neurons that
play a key role in the control of energy balance and body weight
[1]. Glucose regulates not only the excitability of glucose-sensing
neurons but also biochemical events in these cells. In POMC
neurons, glucose increases the levels of hypoxia-inducible factors
that in turn stimulate POMC expression and reduce body weight
[29]. Therefore, hypothalamic neurons are likely to integrate
signals from both leptin and glucose, thus controlling energy
balance and body weight. In the current study, we show that
glucose plays a permissive role in leptin signaling. Glucose
promotes leptin pathways at least in part by inhibiting AMPK.
Results
Glucose plays a permissive role in leptin stimulation of
STAT3 phosphorylation
We have generated and characterized human fibrosarcoma
(c2A
LEPRb/JAK2) that stably expresses LEPRb and JAK2 [30]. To
determine whether glucose levels affect leptin signaling, c2A
LEPRb/
JAK2 cells were grown overnight in serum-free medium supple-
mented with either 5 mM or 25 mM D-glucose and treated with
100 ng/ml leptin for 10 min. Tyrosyl phosphorylation of STAT3
in cell extracts was examined by immunoblotting with anti-
phospho-STAT3 (pTyr
705) antibody (apSTAT3). At 5 mM
glucose, leptin modestly stimulated STAT3 phosphorylation; in
contrast, leptin robustly stimulated STAT3 phosphorylation at
25 mM glucose (Fig. 1A). Glucose enhanced leptin signaling in
both time- and dose-dependent manners. Glucose enhancement
was detected within 30 min and progressively increased for 4 h
(Fig. 1B). Leptin-stimulated STAT3 Tyr
705 phosphorylation also
increased progressively from 5–25 mM glucose (Fig. 1C). To
determine whether glucose increases leptin sensitivity, we
examined leptin dose-responses at 5 or 25 mM D-glucose. Glucose
increased leptin-stimulated STAT3 Tyr
705 phosphorylation at
both low (5–10 ng/ml) and high concentrations (50–100 ng/ml) of
leptin (Fig. 1D). These data suggest that glucose increases both
leptin sensitivity and maximal responses.
To determine whether glucose similarly enhances leptin
signaling in neurons, PC12
LEPRb cells, which stably express
LEPRb [31], were differentiated into neurons with nerve growth
factor (NGF). The neurons were grown overnight in serum-free
medium supplemented with 5 or 25 mM D-glucose and stimulated
with 100 ng/ml leptin for 10 min. Leptin stimulated STAT3
Tyr
705 phosphorylation modestly at 5 mM glucose but robustly at
25 mM glucose (Fig. 1E). Further reduction in glucose (3 mM)
largely abolished leptin signaling (data not shown). To determine
whether glucose enhances leptin signaling in hypothalamic
neurons, LEPRb was stably introduced into GT1-7 cells (GT1-
7
LEPRb), a mouse hypothalamic line [32], and leptin signaling was
examined at low or high levels of D-glucose. At 5 mM glucose,
leptin barely stimulated STAT3 Tyr
705 phosphorylation; in
contrast, leptin robustly stimulated STAT3 phosphorylation at
25 mM glucose (Fig. 1F). Together, these results demonstrate that
glucose plays a permissive role in leptin signaling and dose-
dependently enhances leptin signaling.
Glucose enhances leptin stimulation of JAK2
Leptin stimulates STAT3 phosphorylation by both JAK2-
dependent and -independent mechanisms [31]. To determine
whether glucose is involved in leptin stimulation of JAK2,
c2A
LEPRb/JAK2 cells were incubated overnight with either 5 mM
or 25 mM D-glucose and treated with 100 ng/ml leptin for
10 min. Cell extracts were immunoblotted with anti-phospho-
JAK2 (pTyr
1007/1008) antibody. Phosphorylation of Tyr
1007 in the
activation loop is required for JAK2 activation [33,34]. 25 mM
glucose markedly increased the ability of leptin to stimulate
tyrosyl phosphorylation of both JAK2 and STAT3, compared
with 5 mM glucose (Fig. 2A). Additionally, JAK2 was immuno-
Figure 1. Glucose enhances leptin stimulation of STAT3
phosphorylation. A, c2A
LEPRb/JAK2 cells were grown overnight in
serum-free medium supplemented with 5 or 25 mM glucose and
treated with 100 ng/ml leptin for 10 min. Cell extracts were immuno-
blotted with anti-phospho-STAT3 (pTyr
705)( apSTAT3) or aSTAT3
antibodies. The amounts of phospho-STAT3 and total STAT3 were
quantified using densitometry, and STAT3 phosphorylation was
normalized to the total amount of STAT3. *P,0.05. B, c2A
LEPRb/JAK2
cells were deprived of serum in the presence of 5 mM glucose
overnight. Cells were pretreated with 25 mM glucose for 0, 10, 30, 60,
120 or 240 min, and then treated with 100 ng/ml leptin for 10 min. Cell
extracts were immunoblotted with apSTAT3 or aSTAT3. C, c2A
LEPRb/JAK2
cells were deprived of serum overnight in the presence of 0, 5, 10, 15 or
25 mM glucose, and stimulated with 100 ng/ml leptin for 10 min. Cell
extracts were immunoblotted with apSTAT3 or aSTAT3. D, c2A
LEPRb/JAK2
cells were deprived of serum in the presence of 5 or 25 mM glucose
overnight, and then stimulated with leptin for 10 min at various
concentrations. Cell extracts were immunoblotted with apSTAT3 or
aSTAT3, respectively. E–F, PC12
LEPRb neurons (E) and GT1-7
LEPRb cells (F)
were deprived of serum overnight in 5 or 25 mM glucose and then
treated with 100 ng/ml leptin for 10 min. Cell extracts were immuno-
blotted with apSTAT3 or aSTAT3.
doi:10.1371/journal.pone.0031636.g001
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kinase assay. Leptin barely activated JAK2 at 5 mM glucose but
robustly stimulated JAK2 at 25 nM glucose (Fig. 2B). These
results further support the conclusion that glucose plays a
permissive role in leptin signaling.
Glucose differentially enhances leptin- but not growth
hormone (GH)-stimulated JAK2/STAT pathway
To determine whether glucose similarly enhances the JAK/
STAT pathway in response to other hormones, we generated
c2A
GHR/JAK2 cells that stably express GH receptors (GHR) and
JAK2 [31]. JAK2 binds to GHR and mediates STAT5 tyrosyl
phosphorylation and activation in response to GH [35,36].
c2A
GHR/JAK2 cells were pretreated with 5 mM or 25 mM D-
glucose and stimulated with GH for 15 min. Cell extracts were
immunoblotted with anti-phospho-STAT5 (pTyr694 of STAT5a
or pTyr699 of STAT5b) or anti-phospho-JAK2 (pTyr
1007/1008).
GH stimulated phosphorylation of both STAT5 and JAK2;
surprisingly, glucose did not increase the ability of GH to
stimulate phosphorylation of either STAT5 or JAK2 (Fig. 3A).
To determine whether glucose enhances endogenous GHR/
JAK2/STAT5 pathway, 3T3-F442A cells were grown in the
presence of either 5 mM or 25 mM D-glucose and treated with
GH. GH stimulated phosphorylation of STAT5 and JAK2 to a
similar degree between 5 mM and 25 mM glucose (Fig. 3B).
Thus, glucose starvation specifically suppresses leptin stimulation
of the JAK2/STAT3 pathway but not GH stimulation of the
JAK2/STAT5 pathway. These data also suggest that glucose
starvation-induced suppression of leptin signaling is unlikely to be
caused by nonspecific inhibition of cell signaling and JAK/STAT
pathways.
Glycolysis is required for glucose enhancement of leptin
signaling
To exclude osmolarity as a contributing factor, c2A
LEPRb/JAK2
cells were grown in 5 mM D-glucose supplemented with additional
20 mM L-glucose, sorbitol, or D-glucose, and stimulated with
leptin. D-glucose, but not L-glucose or sorbitol, increased the ability
of leptin to stimulate STAT3 Tyr
705 phosphorylation (Fig. 4A). L-
glucose is unable to be metabolized, raising the possibility that
glycolysis is important for glucose to enhance leptin signaling. To
test this idea, cells were pretreated with 25 mM D-glucose in the
presence or absence of 2-deoxyglucose (2-DG), which blocks
glycolysis. 2-DG prevented D-glucose from enhancing leptin
stimulation of STAT3 phosphorylation (Fig. 4B). In contrast to D-
glucose, neither lactate nor pyruvate enhanced leptin signaling
(Fig. 4C). Both lactate and pyruvate are oxidized via the
tricarboxylic acid cycle; thus, the tricarboxylic acid cycle is not
sufficient to enhance leptin signaling. Therefore, glycolysis is likely
to play a permissive role for leptin signaling.
AMPK mediates glucose regulation of leptin signaling
Glucose metabolism links to oxidative stress and the activation of
themTOR pathway. To determinewhether reactive oxygenspecies
(ROS) mediate glucose action on leptin signaling, c2A
LEPRb/JAK2
cells were treated with 25 mM D-glucose in the presence of the
antioxidant N-acetyl cysteine (NAc) (10 mM). NAc did not inhibit
the ability of glucose to enhance leptin-stimulated Tyr
705 STAT3
phosphorylation (Fig. 5A). Additionally, H2O2 was unable to mimic
glucose action to enhance leptin signaling (Fig. 5B). To examine the
Figure 2. Glucose enhances leptin stimulation of JAK2. A,
c2A
LEPRb/JAK2 cells were deprived of serum in the presence of 5 or
25 mM glucose overnight and then treated with 100 ng/ml leptin for
10 min. Cell extracts were immunoblotted with anti-phospho-JAK2
(pTyr
1007/1008)( apJAK2), aJAK2, apSTAT3, or aSTAT3 as designated. B,
c2A
LEPRb/JAK2 cells were treated with 5 or 25 mM glucose overnight and
then with 100 ng/ml leptin for 10 min. JAK2 in cell extracts was
immunoprecipitated with aJAK2 and subjected to an in vitro kinase
assay. The same blots were immunoblotted with aJAK2.
doi:10.1371/journal.pone.0031636.g002
Figure 3. Glucose does not enhance GH-stimulated phosphor-
ylation of JAK2 and STAT5. A, c2A
GHR/JAK2 cells were deprived of
serum in the presence of 5 or 25 mM glucose overnight and then
treated with GH for 15 min. Cell extracts were immunoblotted with
apSTAT5, aSTAT5, apJAK2 or aJAK2, respectively. B, 3T3-F442A cells
were treated with 5 or 25 mM glucose overnight and then with 50 ng/
ml GH for 15 min. Cell extracts were immunoblotted with the indicated
antibodies.
doi:10.1371/journal.pone.0031636.g003
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inhibitor. Rapamycin did not decrease the ability of glucose to
enhance leptin-stimulated STAT3 phosphorylation (Fig. 5C). In
agreement, L-leucine, a potent activator of mTOR, was also unable
to enhance leptin signaling (Fig. 5D). These data suggest that
oxidative stress and the TORC1 pathway are unlikely to mediate
glucose enhancement of leptin signaling.
Inhibition of glycolysis by either glucose starvation or 2-DG
treatments activates AMPK [37,38], raising the possibility that
AMPK may be involved in D-glucose deficiency-induced
suppression of leptin signaling. To test this idea, c2A
LEPRb/JAK2
cells were treated with AICAR, an AMPK activator. As shown in
Figures 1A and 2A, 25 mM D-glucose increased leptin-stimulated
tyrosyl phosphorylation of STAT3 and JAK2 compared with
5 mM glucose (Fig. 6A, lane 4). Importantly, both 2-DG and
AICAR strongly attenuated the ability of glucose to enhance leptin
signaling (Fig. 6A, lanes 5–6). Both 2-DG and AICAR stimulated
AMPK phosphorylation (pThr
172) (Fig. 6A, panel 5); D-glucose
deficiency also led to AMPK phosphorylation (Fig. 6A, lanes 1–2,
panel 5). AMPK phosphorylation on Thr
172 is required for AMPK
activity and serves as a marker for estimating its activation
[26]. These data suggest that AMPK activation inhibits leptin
stimulation of the JAK2/STAT3 pathway, and that glucose
provides a permissive condition for leptin signaling at least in part
by inhibiting AMPK.
To determine whether AMPK inhibits leptin signaling in
neurons, PC12
LEPRb cells were differentiated into neurons. Both
AICAR and 2-DG suppressed leptin-stimulated tyrosyl phosphor-
ylation of STAT3 at 25 mM glucose in PC12
LEPRb neurons
(Fig. 6B). To determine whether inhibition of AMPK improves
leptin signaling under low glucose conditions, PC12
LEPRb neurons
were pretreated with compound C, a commonly used AMPK
inhibitor, in the presence of 5 mM glucose. Compound C
markedly increased the ability of leptin to stimulate STAT3
phosphorylation (Fig. 6C, lanes 2–3). At 25 mM D-glucose, 2-DG
suppressed leptin-stimulated phosphorylation of STAT3 (Fig. 6C,
lanes 5–6), and compound C reversed 2-DG suppression of leptin
signaling (Fig. 6C, lane 7). These data further confirm that AMPK
inhibits leptin stimulation of the JAK2/STAT3 pathway, and that
glucose enhances leptin signaling at least in part by inhibiting
AMPK.
Figure 4. Glycolysis is required for glucose to enhance leptin
signaling. A, c2A
LEPRb/JAK2 cells were grown overnight in serum-free
medium supplemented with 25 mM D-glucose, 5 mM D-glucose plus
20 mM L-glucose, or 5 mM D-glucose plus 20 mM sorbitol. Cells were
stimulated with 100 ng/ml leptin for 10 min, and cell extracts were
immunoblotted with apSTAT3 or aSTAT3. B, c2A
LEPRb/JAK2 cells were
grown overnight in serum-free medium supplemented with 25 mM D-
glucose, pretreated with 25 mM 2-DG for 3 h, and then treated with
100 ng/ml leptin for 10 min. Cell extracts were immunoblotted with
apSTAT3 or aSTAT3. C. c2A
LEPRb/JAK2 cells were grown overnight
(,15 h) in serum-free medium containing 5 mM D-glucose plus
additional 20 mM lactate, pyruvate, or D-glucose, and stimulated with
100 ng/ml leptin for 10 min. Cell extracts were immunoblotted with
apSTAT3 or aSTAT3.
doi:10.1371/journal.pone.0031636.g004
Figure 5. Oxidative stress, the mTOR pathway, and the p38
MAPK pathway do not mediate glucose enhancement of leptin
signaling. A–B. c2A
LEPRb/JAK2 cells were grown overnight in serum-free
medium supplemented with 5 or 25 mM D-glucose, 10 mM NAc (A) or
200 mMH 2O2 (B). Cells were stimulated with 100 ng/ml leptin for
10 min, and cell extracts were immunoblotted with apSTAT3 or
aSTAT3. C–D. c2A
LEPRb/JAK2 cells were incubated in 5 or 25 mM glucose
overnight, pretreated with 50 nM rapamycin for 1 h (C) or 2 mM L-
leucine for 2 h (D), and then stimulated with 100 ng/ml leptin for
10 min. Cell extracts were immunoblotted with apSTAT3 or aSTAT3.
doi:10.1371/journal.pone.0031636.g005
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Leptin resistance is the primary risk factor for obesity [1].
Upregulation of a number of negative regulators of leptin
signaling, including PTP1b and SOCS3, is likely to contribute to
leptin resistance [39,40,41,42,43]. Conversely, downregulation of
positive regulators, including SH2B1, may also contribute to leptin
resistance [44,45]. Thus, it is important to identify additional
regulators of leptin signaling in order to fully understand energy
homeostasis and body weight regulation. Here we have identified
glucose and AMPK as new regulators of leptin sensitivity.
Both leptin and glucose, acting on hypothalamic neurons,
suppress food intake and weight gain; conversely, leptin deficiency
and brain glucopenia promote hyperphagia and weight gain
[1,21]. However, it is unclear whether leptin and glucose exhibit
crosstalk in hypothalamic neurons. In this study, we report that
glucose is likely to play a permissive role in leptin signaling and to
improve leptin sensitivity in a dose-dependent manner. We
showed that D-glucose deficiency blocks the ability of leptin to
stimulate tyrosyl phosphorylation of JAK2 and STAT3. Addition-
ally, D-glucose enhances leptin signaling in a variety of cell types,
including human c2A fibrosarcoma cells, rat PC12 neurons, and
murine GT1-7 hypothalamic neurons. Glycolysis appears to be
required for leptin signaling, since blocking glycolysis suppressed
leptin signaling and decreased the ability of glucose to increase
leptin stimulation of JAK2 and STAT3 phosphorylation. Surpris-
ingly, glucose did not increase the ability of GH to stimulate the
JAK2/STAT5 pathway. These observations raise the possibility
that glucose or its metabolites may facilitate the coupling between
LEPRb and JAK2 but not between GHR and JAK2.
We also identified AMPK as a potential negative regulator of
leptin sensitivity. AMPK is a molecular energy sensor that is
activated by AMP (associated with low intracellular energy levels)
and a variety of hormones and cytokines [26,27]. Resembling
leptin resistance, activation of hypothalamic AMPK increases food
intake and body weight in mice; in contrast, blocking hypotha-
lamic AMPK increases the anorexigenic effect of leptin [46,47].
We observed that at high levels of glucose (25 mM), AMPK
activity was suppressed and pharmacological activation of AMPK
by either 2-DG or ARCAR markedly reduced the ability of leptin
to stimulate tyrosyl phosphorylation of JAK2 and STAT3.
Conversely, at low levels of glucose, AMPK was highly activated
and leptin signaling was suppressed; pharmacological inhibition of
AMPK robustly enhanced leptin signaling. These results suggest
that glucose plays a permissive role in the maintenance of normal
leptin sensitivity by suppressing AMPK and reversing AMPK
inhibition of leptin signaling. Additionally, these observations raise
the possibility that AMPK may also mediate crosstalk between
leptin and other factors, in addition to glucose, that regulate the
AMPK pathway.
In summary, we described novel crosstalk between leptin and
glucose. Glycolysis provided a permissive condition for leptin to
stimulate the JAK2/STAT3 pathway. We have also identified
AMPK as a potential negative regulator of leptin signaling.
Glucose enhanced leptin signaling at least in part by inhibiting the
ability of AMPK to suppress leptin signaling.
Materials and Methods
Materials
Antibodies against phospho-STAT3(pTyr
705), STAT3, STAT5,
and AMPKa were purchased from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA). Anti-phospho-AMPK (pThr
172) antibody was
from Cell Signaling Technology Inc. (Beverly, MA). Anti-JAK2
antibody was from Millipore Corp. (Bedford, MA). Anti-phospho-
JAK2 (pTyr
1007/1008) and anti-phospho-tyrosine (pY20) antibodies
were from Upstate Biotechnology Inc. (Lake Placid, NY). Anti-
phospho-STAT5 antibody was obtained from Zymed Labs, Inc.
(San Francisco, CA). 5-aminoimidazole-4-carboxamide 1-b-D-
Figure 6. AMPK is involved in glucose enhancement of leptin
signaling. A, c2A
LEPRb/JAK2 cells were deprived of serum overnight (in
25 mM glucose). Cells were treated with 25 mM 2-DG or 2 mM AICAR for
3 h, and then with 100 ng/ml leptin for additional 10 min. Cell extracts
were immunoblottedwith theindicated antibodies. B, PC12
LEPRb neurons
weredeprivedofserumovernightinthepresenceof25 mMglucose,and
treated with 25 mM 2-DG or 2 mM AICAR for 1 h and then with 100 ng/
ml leptin for additional 10 min. Cell extracts were immunoblotted with
the indicated antibodies. C, PC12
LEPRb neurons were incubated overnight
(,15 h) in the presence or absence of 40 mM compound C. Some cells
were pretreated with 2-DG (25 mM) for 1 h as indicated. Cells were
stimulated with 100 ng/ml leptin for 10 min, and cell extracts were
immunoblotted with the indicated antibodies.
doi:10.1371/journal.pone.0031636.g006
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Bioscience Inc. (La Jolla, CA). Recombinant mouse leptin was
from the National Hormone and Peptide Program, NIDDK,
National Institutes of Health (Torrance, CA). Compound C and
nerve growth factor were from Sigma-Aldrich.
Cell Culture, Neuronal Differentiation, and
Immunoblotting
c2A
LEPRb/JAK2, c2A
GHR/JAK2 and PC12
LEPRb cell lines have
been described previously [31]. GT1-7
LEPRb cell lines were
derived from mouse hypothalamic tumor cells (GT1-7) [32].
LEPRb was stably introduced into GT1-7 cells via LEPRb
retroviral infection [31]. c2A
LEPRb/JAK2 and c2A
GHR/JAK2 cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 5% heat-inactivated fetal bovine serum (FBS) in the
presence of 25 mM glucose, 100 units/ml penicillin and 100 mg/
ml streptomycin at 37uC in a humidified atmosphere of 5% CO2.
PC12
LEPRb cells were grown on collagen-coated dishes at 37uCi n
5% CO2 in DMEM supplemented with 25 mM glucose, 100
units/ml penicillin, 100 mg/ml streptomycin, 10% heat-inactivat-
ed horse serum, and 5% FBS. To induce neuronal differentiation,
PC12
LEPRb cells were cultured for 3 days in DMEM supplemented
with 25 mM glucose, 2% horse serum, 1% FBS, 100 ng/ml NGF,
100 units/ml penicillin, and 100 mg/ml streptomycin. For
immunoblotting, cells were deprived of serum overnight in
DMEM containing 0.6% bovine serum albumin (BSA) in the
presence of 5 mM D-glucose supplemented with additional
20 mM D-glucose, L-glucose, sorbitol, pyruvate, or lactate. Cells
were pretreated with or without the indicated compounds, and
then treated with leptin. Cell extracts were prepared as described
previously [48], and immunoblotted with the indicated antibodies.
Blots were visualized using Odyssey Infrared Imaging System (LI-
COR Biosciences, Lincoln, NE).
In Vitro Kinase Assays
JAK2 in cell extracts was immunoprecipitated with anti-JAK2
antibody and absorbed on protein A-agarose beads. The beads
were washed extensively with a kinase reaction buffer (50 mM
HEPES, pH 7.6, 10 mM MnCl2, 100 mM NaCl, 0.5 mM
dithiothreitol, 1 mM Na3VO4) and then incubated at room
temperature for 30 min in the kinase reaction buffer supplemented
with [c-
32P]ATP (10 mCi), 20 mM cold ATP, 10 mg/ml aprotinin,
and 10 mg/ml leupeptin. The kinase reaction was stopped by
washing the beads with lysis buffer. JAK2 was eluted from the
beads by boiling for 5 min in the SDS-PAGE sample buffer. JAK2
was resolved by SDS-PAGE and transferred onto nitrocellulose
membranes. JAK2 autophosphorylation was detected by autora-
diography. The same blots were immunoblotted with anti-JAK2
antibody.
Statistical Analysis
Data are presented as means 6 SEM. Differences between
groups were analyzed by two-tailed Student’s t test. P,0.05 was
considered statistically significant.
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